×
We couldn’t find any recent recommendations for this company (matched by symbol or BSE code). Please check back later.
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.09 | 84.8 |
| Triochem Products Ltd., | 2.21 | -0.31 | NA | -1.25 | 0 | |
| AURO LABORATORIES LTD. | 31.91 | -1.05 | 27.74 | -0.17 | 144.0 | 208.0 |
| PARNAX LAB LTD. | 535.60 | 32.75 | 533.76 | 2.85 | 144 | 13.4 |
| TYCHE INDUSTRIES LTD. | 144.65 | 24.31 | 127.00 | 2.37 | 140 | 11.5 |
Auro Laboratories Ltd., with Security Code 530233, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 13.5 | 10.2 | 13.4 | 18.0 | 12.1 | 5.7 | 3.1 | 3.1 | 7.4 | 2.8 |
| Expenses | 11.2 | 9.0 | 10.4 | 13.9 | 9.0 | 4.4 | 2.4 | 2.6 | 6.5 | 2.7 |
| Operating Profit | 2.4 | 1.2 | 3.0 | 4.1 | 3.1 | 1.3 | 0.7 | 0.4 | 0.9 | 0.0 |
| OPM % | 17.38% | 11.32% | 22.56% | 22.69% | 25.36% | 23.13% | 23.32% | 14.53% | 12.03% | 1.19% |
| Other Income | 0.6 | 0.4 | 0.3 | 0.4 | 0.4 | 0.2 | 0.3 | 0.1 | 0.1 | 0.4 |
| Interest | 0.1 | 0.3 | 0.3 | 0.4 | 0.3 | 0.3 | 0.3 | 0.2 | 0.3 | 0.3 |
| Depreciation | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 |
| Profit before tax | 2.5 | 1.0 | 2.7 | 3.8 | 2.9 | 1.0 | 0.5 | 0.1 | 0.4 | -0.1 |
| Tax % | -29.6% | -27.9% | -27.8% | -27.8% | -18.6% | -25.1% | -25.1% | -25% | 0% | 0% |
| Net Profit | 1.8 | 0.7 | 2.0 | 2.7 | 2.3 | 0.8 | 0.4 | 0.1 | 0.4 | -0.1 |
| EPS in Rs | 2.86 | 1.14 | 3.16 | 4.39 | 3.72 | 1.21 | 0.57 | 0.08 | 0 | 0 |
No Consolidated data available.
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 3% |
| 3 Years: | 0% |
| TTM: | -57% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 30% |
| 5 Years: | 12% |
| 3 Years: | 3% |
| TTM: | -52% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 38% |
| 5 Years: | 48% |
| 3 Years: | 40% |
| 1 Year: | 13% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | 0% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| News Date ▲▼ | Headline ▲▼ | Issuer Entity ▲▼ | Issuer Type ▲▼ | Order Size ▲▼ | Time Period ▲▼ | |
|---|---|---|---|---|---|---|
| Loading company updates… | ||||||
We couldn’t find any filings or updates in the Company News collection for this BSE code.
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|